Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peters

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
European Urology Open Science|December 6, 2024
Comparison of Perioperative Outcomes of Holmium Laser Enucleation of the Prostate for Standard (≤149 ml) Versus Very Large (≥150 ml) Prostate Glands: Retrospective Analysis of a Propensity Score Matched Cohort of 326 PatientsJacob Schmidt, Jorien Krediet, Holger Beutel, et al.
Journal of Clinical Medicine|September 13, 2025
Long-Term Outcomes of Living Kidney Donors Left with Multiple Renal Arteries: A Retrospective Cohort Study from a Single CenterThomas Kurz, Jacob Schmidt, Isabel Lichy, et al.
Journal of Clinical Medicine|August 10, 2024
Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant RecipientsLutz Liefeldt, Johannes Waiser, Friederike Bachmann, et al.
Journal of the American Academy of Audiology|October 18, 2013
Evaluation of speech recognition of cochlear implant recipients using a personal digital adaptive radio frequency systemJace Wolfe, Mila Morais, Erin Schafer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 14, 2023
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B miceArjan van der Flier, Vu Hong, Zhan Liu, et al.
Anti-Cancer Drugs|August 13, 2005
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in ratsClaudia Abramjuk, Klaus Jung, Hans-Willi Krell, et al.
International Journal of Cardiology|October 5, 2011
Clinical outcomes following a strategy of optimized medical management and selective "downstream" procedures following coronary computed tomography angiographySeth Uretsky, Alan Rozanski, Azhar Supariwala, et al.
The Prostate|July 17, 2025
Minimally Invasive Holmium Laser Enucleation of the Prostate (MiLEP) Vs. HoLEP: Retrospective Analysis of Perioperative Outcomes in a Propensity Score-Matched CohortJacob Schmidt, Bernhard Ralla, Andreas Maxeiner, et al.
Cancers|July 12, 2025
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic ChallengesJacob Schmidt, Malte Lehnert, Isabel Lichy, et al.
Cellular Immunology|January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceSriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
European Urology Open Science|December 6, 2024
Comparison of Perioperative Outcomes of Holmium Laser Enucleation of the Prostate for Standard (≤149 ml) Versus Very Large (≥150 ml) Prostate Glands: Retrospective Analysis of a Propensity Score Matched Cohort of 326 PatientsJacob Schmidt, Jorien Krediet, Holger Beutel, et al.
Journal of Clinical Medicine|September 13, 2025
Long-Term Outcomes of Living Kidney Donors Left with Multiple Renal Arteries: A Retrospective Cohort Study from a Single CenterThomas Kurz, Jacob Schmidt, Isabel Lichy, et al.
Journal of Clinical Medicine|August 10, 2024
Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant RecipientsLutz Liefeldt, Johannes Waiser, Friederike Bachmann, et al.
Journal of the American Academy of Audiology|October 18, 2013
Evaluation of speech recognition of cochlear implant recipients using a personal digital adaptive radio frequency systemJace Wolfe, Mila Morais, Erin Schafer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 14, 2023
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B miceArjan van der Flier, Vu Hong, Zhan Liu, et al.
Anti-Cancer Drugs|August 13, 2005
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in ratsClaudia Abramjuk, Klaus Jung, Hans-Willi Krell, et al.
International Journal of Cardiology|October 5, 2011
Clinical outcomes following a strategy of optimized medical management and selective "downstream" procedures following coronary computed tomography angiographySeth Uretsky, Alan Rozanski, Azhar Supariwala, et al.
The Prostate|July 17, 2025
Minimally Invasive Holmium Laser Enucleation of the Prostate (MiLEP) Vs. HoLEP: Retrospective Analysis of Perioperative Outcomes in a Propensity Score-Matched CohortJacob Schmidt, Bernhard Ralla, Andreas Maxeiner, et al.
Cancers|July 12, 2025
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic ChallengesJacob Schmidt, Malte Lehnert, Isabel Lichy, et al.
Cellular Immunology|January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceSriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
Pageof 10